Outcomes Group Subgroup N WMD 95%CI p I 2 (%)(WMD) value FBG Duration ≤12 weeks 5 −0.39 −1.12, 0.34 0.005 73.00 0.293 >12 weeks 7 −0.78 −1.47, −0.08 0.002 71.10 0.029 Frequency ≤3 times/week 4 −0.67 −1.51, 0.17 0.001 82.10 0.12 >3 times/week 8 −0.57 −1.22, 0.08 0.004 66.10 0.084 Time ≤50 min 5 −0.06 −0.67, 0.55 0.036 61.00 0.84 >50 min 7 −1.04 −1.70, −0.37 0.004 69.00 0.002 HbA1c Duration ≤12 weeks 4 −0.82 −1.24, −0.39 0.243 28.20 ≤0.01 >12 weeks 5 −0.88 −2.07, 0.30 ≤0.01 96.90 0.144 Frequency ≤3 times/week 4 −0.77 −2.44, 0.89 ≤0.01 97.10 0.363 >3 times/week 5 −0.91 −1.56, −0.25 ≤0.01 84.90 0.007 Time ≤50 min 3 −0.88 −2.02, 0.27 ≤0.01 90.70 0.132 >50 min 6 −0.87 −1.91, 0.18 ≤0.01 95.30 0.103 TC Duration ≤12 weeks 4 −0.61 −1.11, −0.11 ≤0.01 85.80 0.016 >12 weeks 5 −0.34 −0.81, 0.13 0.027 63.50 0.159 Frequency ≤3 times/week 2 0.02 −0.34, 0.38 0.441 0.00 0.902 >3 times/week 7 −0.58 −0.94, −0.22 ≤0.01 76.80 0.002 Time ≤50 min 3 −0.61 −1.31, 0.10 ≤0.01 89.80 0.091 >50 min 6 −0.4 −0.77, −0.03 0.021 62.40 0.036 TG Duration ≤12 weeks 3 −0.28 −0.40, −0.16 0.369 0.00 ≤0.01 >12 weeks 5 −0.09 −0.45, 0.27 0.018 66.50 0.625 Frequency ≤3 times/week 2 −0.2 −0.38, −0.04 0.854 0.00 0.016 >3 times/week 6 −0.19 −0.42, 0.04 0.008 68.10 0.098 Time ≤50 min 2 0.09 −0.62, 0.79 0.001 90.70 0.808 >50 min 6 −0.28 −0.40, −0.17 0.719 0.00 ≤0.01 HDL-C Duration ≤12 weeks 4 0.17 0.05, 0.28 0.072 57.20 0.004 >12 weeks 4 0.00 −0.08, 0.08 0.67 0.00 0.967 Time ≤50 min 3 0.09 −0.07, 0.25 0.024 73.30 0.268 >50 min 3 0.11 0.01, 0.20 0.208 32.00 0.038 LDL-C Duration ≤12 weeks 2 −0.62 −0.82, −0.43 0.349 0.00 ≤0.01 >12 weeks 4 −0.17 −0.57, 0.23 0.011 73.20 0.407 Time ≤50 min 2 −0.05 −0.67, 0.56 0.005 87.30 0.868 >50 min 4 −0.47 −0.83, −0.12 0.047 62.30 0.008